---
title: "Weihai Baihe Biology Technological Co., Ltd (603102.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603102.SH.md"
symbol: "603102.SH"
name: "Weihai Baihe Biology Technological Co., Ltd"
industry: "Personal Care Products"
datetime: "2026-05-20T13:15:00.388Z"
locales:
  - [en](https://longbridge.com/en/quote/603102.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603102.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603102.SH.md)
---

# Weihai Baihe Biology Technological Co., Ltd (603102.SH)

## Company Overview

Weihai Baihe Biology Technological Co., Ltd., together with its subsidiary, Weihai Lily Functional Food Technology Research Institute Limited Company, research, develops, manufactures, and sells nutrition and health food in China and internationally. The company offers health food; nutritious food for feminine glamour, male energy, elderly care, pregnancy, babies, and childcare, as well as nutritional soft candies; special diet products comprising supplementary food and nutritional supplements, nutritional supplements for pregnant women and lactating mothers, and sports nutrition supplements; official approval services for health food declarations; and testing suits services. It provides its products in the form of soft and hard capsules, tablets, powders, oral liquids, drops, and bottles. The company sells its products under the Biohek, Hongyangshen, Yunyangyan, Forzal, Zulixing, and Nengbeijian brands.

| Item | Detail |
|------|--------|
| Industry | Personal Care Products |
| Exchange | CN Market |
| Website | [www.baiheshengwu.com](https://www.baiheshengwu.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: B (0.32)**

**Industry**: Personal Care Products

| Metric | Value |
|--------|-------|
| Industry Ranking | 16 / 28 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 16.60% |  |
| Net Profit YoY | -12.56% |  |
| P/B Ratio | 1.52 |  |
| Dividend Ratio | 1.82% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2564553486.12 |  |
| Revenue | 957577043.37 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 7.36% | B |
| Profit Margin | 12.78% | B |
| Gross Margin | 37.75% | B |
| Revenue YoY | 16.60% | B |
| Net Profit YoY | -12.56% | D |
| Total Assets YoY | 6.03% | C |
| Net Assets YoY | 4.74% | C |
| Cash Flow Margin | 119.37% | C |
| OCF YoY | 16.60% | B |
| Turnover | 0.50 | C |
| Gearing Ratio | 12.54% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Weihai Baihe Biology Technological Co., Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "16.60%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-12.56%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.52",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.82%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "2564553486.12",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "957577043.37",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "7.36%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "12.78%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "37.75%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "16.60%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-12.56%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "6.03%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "4.74%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "119.37%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "16.60%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.50",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "12.54%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 20.99 | 3/28 | 23.22 | 21.80 | 20.28 |
| PB | 1.52 | 7/28 | 1.76 | 1.68 | 1.63 |
| PS (TTM) | 2.68 | 14/28 | 3.46 | 3.34 | 3.18 |
| Dividend Yield | 1.82% | 11/28 | 1.75% | 1.70% | 1.63% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Proya (603605.SH) | A | D | A | B | C | B |
| 02 | BYHEALTH (300146.SZ) | B | C | C | A | C | B |
| 03 | BTN (300957.SZ) | B | C | B | B | C | B |
| 04 | FLYCO (603868.SH) | A | D | A | A | C | B |
| 05 | Shanghai Jahwa (600315.SH) | C | B | B | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/603102.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/603102.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/603102.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/603102.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**